Human Menopausal Gonadotropin (HMG) is a sterile preparation containing glycoprotein gonadotropin extracted from human post-menopausal urine. It contains both Follicle Stimulating Hormone (FSH) and Luteinising Hormone (LH).
The substance has the property in females of stimulating growth and maturation of ovarian follicles and property in males of maintaining and stimulating testicular, interstitial cells related to testosterone production and of being responsible for the full development and maturation of spermatozoa in the seminiferous tubules.
The substance is indicated for the induction of ovulation in the anovulatory woman with regular or irregular cells. For men, it is indicated for the stimulation of spermatogenesis in men who have primary or secondary hypogonadotropic hypogonadism.
Haoran Biopharma can supply bulk HMG with the following specifications. Products of various specifications can also be prepared according to customers' requests.
Appearance |
Almost White or slightly yellow powder |
Solubility |
Freely soluble |
Identification |
Identified |
FSH activity |
Not less than 200 IU-FSH/mg |
LH activity |
Not less than 200 IU-LH/mg |
FSH:LH |
About 1:1 |
Water |
Not more than 5.0% |
Residual Solvent |
0.5% |
Bacterial endotoxins |
Not more than 1.0 EU/FSH IU |
Abnormal toxicity |
Negative at 100 IU/0.5ml/mouse |
HIV I+II antibody |
Negative |
Hepatitis B surface antigen |
Negative |
HCV antibodies |
Negative |